2023
Association of Population Well-Being With Cardiovascular Outcomes
Spatz E, Roy B, Riley C, Witters D, Herrin J. Association of Population Well-Being With Cardiovascular Outcomes. JAMA Network Open 2023, 6: e2321740. PMID: 37405774, PMCID: PMC10323707, DOI: 10.1001/jamanetworkopen.2023.21740.Peer-Reviewed Original ResearchConceptsPopulation health factorsCVD mortalityCoronary heart diseaseCross-sectional studyHeart diseaseCardiovascular diseaseSecondary outcomesHealth factorsCardiovascular outcomesHeart failureCardiovascular healthMortality rateCounty-level ratesLower CVD mortalityTotal CVD mortalityCardiovascular death ratesAcute myocardial infarctionTotal heart diseaseEffect sizePrimary outcomeHighest quintileLowest quintileMyocardial infarctionNational HealthMAIN OUTCOME
2010
Beyond insurance coverage: Usual source of care in the treatment of hypertension and hypercholesterolemia. Data from the 2003-2006 National Health and Nutrition Examination Survey
Spatz ES, Ross JS, Desai MM, Canavan ME, Krumholz HM. Beyond insurance coverage: Usual source of care in the treatment of hypertension and hypercholesterolemia. Data from the 2003-2006 National Health and Nutrition Examination Survey. American Heart Journal 2010, 160: 115-121. PMID: 20598981, PMCID: PMC3025407, DOI: 10.1016/j.ahj.2010.04.013.Peer-Reviewed Original ResearchConceptsTreatment of hypertensionNutrition Examination SurveyInsurance statusMedication treatmentExamination SurveyNational HealthUsual sourceAdult Treatment Panel III recommendationsJoint National Committee 7Multivariable logistic regression modelingInsurance coverageSeparate multivariable modelsChronic disease managementLogistic regression modelingHigh-quality careRace/ethnicityCardiovascular diseaseMultivariable modelStratified analysisHypertensionHypercholesterolemiaRegular sourceCareDisease managementIndependent effects
2009
From Here to JUPITER
Spatz ES, Canavan ME, Desai MM. From Here to JUPITER. Circulation Cardiovascular Quality And Outcomes 2009, 2: 41-48. PMID: 20031811, DOI: 10.1161/circoutcomes.108.832592.Peer-Reviewed Original ResearchMeSH KeywordsAgedBiomarkersCardiovascular DiseasesC-Reactive ProteinEvidence-Based MedicineFemaleHealth SurveysHumansHydroxymethylglutaryl-CoA Reductase InhibitorsInflammation MediatorsLipoproteins, LDLMaleMiddle AgedNutrition SurveysPatient SelectionPractice Guidelines as TopicRandomized Controlled Trials as TopicRisk AssessmentRisk FactorsTime FactorsConceptsHigh-sensitivity C-reactive proteinLow-density lipoproteinStatin therapyC-reactive proteinElevated high-sensitivity C-reactive protein levelsHigh-sensitivity C-reactive protein levelsElevated low-density lipoprotein levelsGoal low-density lipoproteinIntervention Trial Evaluating RosuvastatinC-reactive protein levelsOlder personsLow-density lipoprotein levelsUse of statinsNutrition Examination SurveyCardiovascular riskMetabolic syndromeLipoprotein levelsPrimary preventionExamination SurveyTreatment recommendationsNational HealthElderly adultsTherapyStatinsOlder adults
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply